These results indicate that ATF5 overexpression increases tumorigenicity and enhances the TIC-like phenotype in bladder cancer cells, thereby providing hope for developing novel therapeutic strategy to prevent BLCA recurrence. Here, ATF5 is linked to urinary bladder carcinoma.